Finance
Key changes to Medicare Advantage plans in Boston are forcing patients, like cancer survivor Eldon Clingan, to seek new providers.
Technology
While a drug for Angelman syndrome failed in trials, experts believe other experimental therapies may still hold promise for neurological conditions.
Technology
The FDA is revisiting its stance on botanical drugs as hurdles persist for clozapine use and pig kidneys emerge as a potential bridge for transplants.
Technology
A recent report highlights that disabled workers may face significant health insurance coverage losses as Medicaid work requirements are set to change.
Technology
Bristol Myers Squibb has paused its CAR-T therapy trials for autoimmunity due to severe side effects, raising questions about transparency.
Technology
The conflict over measles death counts between CDC leadership and Pennsylvania undermines public health efforts in addressing the outbreak.
Technology
The Lindsay Clancy case highlights severe issues within the U.S. healthcare system, revealing the dangers of fragmented care and lack of communication among providers.
Sports
The FDA's removal of clozapine's monitoring requirements is pivotal, but fear still hinders clinicians from prescribing it to young patients with schizophrenia.
Technology
Recent findings confirm that recipients of gene-edited pig kidneys can later receive human organ transplants, marking a significant milestone for xenotransplantation.
Technology
The trial's deadlock raises significant concerns for mental health professionals, especially in the context of postpartum care.
Technology
A new round of pharmaceutical price cuts has been announced, but crucial details and implications remain unclear.
Technology
Novartis celebrates a significant milestone with its BTK inhibitor for multiple sclerosis, advancing the treatment landscape for the disease.
Technology
Recent drug pricing agreements expand to additional companies, while Novartis and Bristol Myers suspend cell therapy trials due to safety concerns.
Finance
Recent research reveals that Paxlovid, a popular Covid-19 treatment, offers no benefit for long Covid patients compared to placebo.
Technology
The House is poised to vote on a funding bill that would block Trump's initiative to control federal research grants, targeting bipartisan support.